{"id":11360,"date":"2020-03-29T21:14:32","date_gmt":"2020-03-29T15:44:32","guid":{"rendered":"https:\/\/www.rootsanalysis.com\/blog\/?p=11360"},"modified":"2026-07-23T15:43:21","modified_gmt":"2026-07-23T10:13:21","slug":"covid-19-impact-on-cell-and-gene-therapy-manufacturing-market","status":"publish","type":"post","link":"https:\/\/www.rootsanalysis.com\/blog\/covid-19-impact-on-cell-and-gene-therapy-manufacturing-market\/","title":{"rendered":"Cell and Gene Therapy Manufacturing: COVID-19 Impact"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">With close to half-million infections and the economy showing signs of the 2008 financial crisis, COVID-19 has impacted several industries. Government institutes and industry players have announced various steps to deal with the ongoing situation. In this article, we will highlight the developments in the cell and gene therapy manufacturing industry amid the ongoing COVID-19 crisis. In addition, we will also discuss the impact of COVID-19 on the <a href=\"https:\/\/www.rootsanalysis.com\/blog\/cell-therapy-manufacturing-market-update-compal-and-university-to-set-up-gtp-lab\/\">cell therapy manufacturing<\/a> industry.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Recent Developments in Cell and Gene Therapy Manufacturing Market<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Last week,  Thermo Fisher announced its plan to open a cell and gene therapy manufacturing collaboration center in Princeton. This development was as part of a USD 475 million investment by the company in its biopharma capabilities. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In the earlier week, Univercells&nbsp;announced the launch of contract development and manufacturing organization (CDMO), Exothera. Specifically, the CDMO was launched to support cell therapy developers with process development and <a href=\"https:\/\/www.rootsanalysis.com\/reports\/viral-vectors-non-viral-vectors-and-gene-therapy-manufacturing-market-\/274.html\">viral vector manufacturing<\/a>.&nbsp; <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Last month, we saw an&nbsp;investment of over \u20ac50 million&nbsp;by&nbsp;Gamma Biosciences&nbsp;to push to market&nbsp;Univercells\u2019 cell and gene therapy manufacturing technology. The technology has been designed to reduce the costs of viral vector production for gene therapies.&nbsp;Check other recent innovations in the <a href=\"https:\/\/www.rootsanalysis.com\/reports\/cell-therapy-manufacturing\/285.html\">cell therapy manufacturing market<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In addition to these,  several players have also announced the development of cell therapy-based programs for the treatment of COVID-19. Below, we have added some of the tweets discussing the development of potential cell therapy-based solutions in COVID-19.<\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-rich is-provider-x wp-block-embed-x\"><div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"twitter-tweet\" data-width=\"550\" data-dnt=\"true\"><p lang=\"en\" dir=\"ltr\">Celularity has a powerful therapy for <a href=\"https:\/\/x.com\/hashtag\/COVID19?src=hash&amp;ref_src=twsrc%5Etfw\">#COVID19<\/a>. It\u2019s called placental-derived Natural Killer (NK) cells. This work was pioneered by @HaririRobert <a href=\"https:\/\/x.com\/celularity?ref_src=twsrc%5Etfw\">@Celularity<\/a>. New evidence that the placenta protects the fetus in infected mothers is critical info.<a href=\"https:\/\/t.co\/UvVKyyyQb3\">https:\/\/t.co\/UvVKyyyQb3<\/a><\/p>&mdash; Peter H. Diamandis, MD (@PeterDiamandis) <a href=\"https:\/\/x.com\/PeterDiamandis\/status\/1244001839349039109?ref_src=twsrc%5Etfw\">March 28, 2020<\/a><\/blockquote><script async src=\"https:\/\/platform.x.com\/widgets.js\" charset=\"utf-8\"><\/script>\n<\/div><\/figure>\n\n\n\n<figure class=\"wp-block-embed aligncenter is-type-rich is-provider-x wp-block-embed-x\"><div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"twitter-tweet\" data-width=\"550\" data-dnt=\"true\"><p lang=\"en\" dir=\"ltr\">PepVax announces it has begun development of SMARTmid\u2122-based coronavirus cell therapy to address the global pandemic threat <a href=\"https:\/\/t.co\/4UKqYiEmJL\">https:\/\/t.co\/4UKqYiEmJL<\/a> <a href=\"https:\/\/t.co\/9fl5gCiRsn\">pic.twitter.com\/9fl5gCiRsn<\/a><\/p>&mdash; PR Distribution (@PRDistributionC) <a href=\"https:\/\/x.com\/PRDistributionC\/status\/1243735584247631872?ref_src=twsrc%5Etfw\">March 28, 2020<\/a><\/blockquote><script async src=\"https:\/\/platform.x.com\/widgets.js\" charset=\"utf-8\"><\/script>\n<\/div><\/figure>\n\n\n\n<figure class=\"wp-block-embed is-type-rich is-provider-x wp-block-embed-x\"><div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"twitter-tweet\" data-width=\"550\" data-dnt=\"true\"><p lang=\"en\" dir=\"ltr\">Lattice Biologics is recruiting 10 patients for it Phase 1 clinical trial in Seattle to assess its <a href=\"https:\/\/x.com\/hashtag\/stemcell?src=hash&amp;ref_src=twsrc%5Etfw\">#stemcell<\/a> therapy, AmnioBoost, for the treatment of acute respiratory syndrome related to <a href=\"https:\/\/x.com\/hashtag\/Coronavirus?src=hash&amp;ref_src=twsrc%5Etfw\">#Coronavirus<\/a>.<a href=\"https:\/\/t.co\/zzaiaePjpw\">https:\/\/t.co\/zzaiaePjpw<\/a> <a href=\"https:\/\/x.com\/LatticeBio?ref_src=twsrc%5Etfw\">@LatticeBio<\/a><\/p>&mdash; BioInformant (@StemCellMarket) <a href=\"https:\/\/x.com\/StemCellMarket\/status\/1242963510650380288?ref_src=twsrc%5Etfw\">March 25, 2020<\/a><\/blockquote><script async src=\"https:\/\/platform.x.com\/widgets.js\" charset=\"utf-8\"><\/script>\n<\/div><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">Impact of COVID-19 on Cell and Gene Therapy Manufacturing<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Roots Analysis has put together a proprietary model taking into consideration several parameters to evaluate the impact of COVID-19 on the cell and gene therapy manufacturing market. The parameters considered for the analysis include:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>The breadth of the impact<\/li>\n\n\n\n<li>Length of the impact<\/li>\n\n\n\n<li>The capability of developers (in terms of cash flow and financial well-being)<\/li>\n\n\n\n<li>Regulatory environment<\/li>\n\n\n\n<li>Attitude towards outsourcing<\/li>\n\n\n\n<li>In-house investments<\/li>\n\n\n\n<li>Adoption of novel technologies (closed automated processing platforms, novel vectors)<\/li>\n<\/ol>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"507\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Impact-of-COVID-19-on-Cell-and-Gene-Therapy-Manufacturing-Roots.webp\" alt=\"COVID-19 Impact on cell and gene therapy manufacturing Model\" class=\"wp-image-18979\" style=\"object-fit:contain;width:800px;height:385px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Impact-of-COVID-19-on-Cell-and-Gene-Therapy-Manufacturing-Roots.webp 1024w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Impact-of-COVID-19-on-Cell-and-Gene-Therapy-Manufacturing-Roots-300x149.webp 300w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Impact-of-COVID-19-on-Cell-and-Gene-Therapy-Manufacturing-Roots-768x380.webp 768w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">One of the key concerns already looming across the cell and gene therapy manufacturing industry is the lack of sufficient vector manufacturing capacity (check other <a href=\"https:\/\/www.rootsanalysis.com\/blog\/vector-manufacturing-market-opinion-leaders-highlight-key-concerns\/\" target=\"_blank\" rel=\"noreferrer noopener\">key concerns<\/a> here). The ongoing COVID-19 crisis is likely to put additional pressure on the vector manufacturers to meet the future demand for cell and gene therapies. If the vector manufacturers are unable to meet the increased demand, it is important for therapy developers to look beyond viral vectors. In fact, several players have already adopted novel vectors beyond the traditionally used AAV vectors.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">It will be critical for the developers to seek clarity on the supply chain challenges. This requires close, transparent collaborations between the therapy developers and manufacturers (check this <a href=\"https:\/\/www.rootsanalysis.com\/blog\/growing-cell-and-gene-therapy-market-vector-manufacturers-make-merry\/\">article<\/a> for details on the cell therapy CDMOs)<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">A Rise in Demand for Supply Chain Management Solutions<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Given the current ambiguity across the supply chain, we should expect more players to adopt digital solutions for the management of the cell therapy supply chain. In one of our recent reports, we identified more than 160 innovative software-enabled systems that have been developed for managing the cell and advanced therapies supply chain. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In fact, a few weeks ago, one of the leading supply chain solution providers,&nbsp;TrakCel announced a non-exclusive&nbsp;strategic partnership with Ori Biotech&nbsp;to achieve supply chain coordination within closed-system manufacturing.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The cell and gene therapy manufacturing market is in its initial stages. These manufacturers are still trying to find novel solutions to the challenges. The ongoing pandemic is either likely to accelerate the development of these solutions, or significantly hamper it. However, history is on the side of the therapy developers. If the players are able to get through the next 3-4 months phase, we should see a stronger and more structured industry. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">To know more about the impact of COVID-19 on cell and therapy manufacturing, drop a note at rohit.kumar@rootsanalysis.com.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">You can also download the&nbsp;<a href=\"https:\/\/www.rootsanalysis.com\/reports\/285\/request-sample.html\">SAMPLE REPORT<\/a>&nbsp;on cell therapies by Roots Analysis.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>With close to half-million infections and the economy showing signs of the 2008 financial crisis, COVID-19 has impacted several industries. Government institutes and industry players have announced various steps to deal with the ongoing situation. In this article, we will highlight the developments in the cell and gene therapy manufacturing industry amid the ongoing COVID-19 [&hellip;]<\/p>\n","protected":false},"author":21,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[118,47,310],"tags":[153,48],"class_list":["post-11360","post","type-post","status-publish","format-standard","hentry","category-cell-therapy","category-gene-therapy","category-vector-manufacturing","tag-cell-therapy","tag-gene-therapy"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>COVID-19 Reshaped Cell and Gene Therapy Manufacturing<\/title>\n<meta name=\"description\" content=\"According to Roots Analysis, the pandemic is likely to accelerate the development of cell and gene therapy manufacturing\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rootsanalysis.com\/blog\/covid-19-impact-on-cell-and-gene-therapy-manufacturing-market\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"COVID-19 Reshaped Cell and Gene Therapy Manufacturing\" \/>\n<meta property=\"og:description\" content=\"According to Roots Analysis, the pandemic is likely to accelerate the development of cell and gene therapy manufacturing\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rootsanalysis.com\/blog\/covid-19-impact-on-cell-and-gene-therapy-manufacturing-market\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RootsAnalysis\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-03-29T15:44:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-23T10:13:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Impact-of-COVID-19-on-Cell-and-Gene-Therapy-Manufacturing-Roots.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"507\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Gaurav Chaudhary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:site\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gaurav Chaudhary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/covid-19-impact-on-cell-and-gene-therapy-manufacturing-market\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/covid-19-impact-on-cell-and-gene-therapy-manufacturing-market\\\/\"},\"author\":{\"name\":\"Gaurav Chaudhary\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/e8e0ebc31296140424e1e7fcc11331bc\"},\"headline\":\"Cell and Gene Therapy Manufacturing: COVID-19 Impact\",\"datePublished\":\"2020-03-29T15:44:32+00:00\",\"dateModified\":\"2026-07-23T10:13:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/covid-19-impact-on-cell-and-gene-therapy-manufacturing-market\\\/\"},\"wordCount\":677,\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/covid-19-impact-on-cell-and-gene-therapy-manufacturing-market\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/Impact-of-COVID-19-on-Cell-and-Gene-Therapy-Manufacturing-Roots.webp\",\"keywords\":[\"Cell Therapy\",\"Gene Therapy\"],\"articleSection\":[\"Cell Therapy\",\"Gene Therapy\",\"Vector Manufacturing\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/covid-19-impact-on-cell-and-gene-therapy-manufacturing-market\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/covid-19-impact-on-cell-and-gene-therapy-manufacturing-market\\\/\",\"name\":\"COVID-19 Reshaped Cell and Gene Therapy Manufacturing\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/covid-19-impact-on-cell-and-gene-therapy-manufacturing-market\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/covid-19-impact-on-cell-and-gene-therapy-manufacturing-market\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/Impact-of-COVID-19-on-Cell-and-Gene-Therapy-Manufacturing-Roots.webp\",\"datePublished\":\"2020-03-29T15:44:32+00:00\",\"dateModified\":\"2026-07-23T10:13:21+00:00\",\"description\":\"According to Roots Analysis, the pandemic is likely to accelerate the development of cell and gene therapy manufacturing\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/covid-19-impact-on-cell-and-gene-therapy-manufacturing-market\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/covid-19-impact-on-cell-and-gene-therapy-manufacturing-market\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/covid-19-impact-on-cell-and-gene-therapy-manufacturing-market\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/Impact-of-COVID-19-on-Cell-and-Gene-Therapy-Manufacturing-Roots.webp\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/Impact-of-COVID-19-on-Cell-and-Gene-Therapy-Manufacturing-Roots.webp\",\"width\":1024,\"height\":507},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/covid-19-impact-on-cell-and-gene-therapy-manufacturing-market\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cell and Gene Therapy Manufacturing: COVID-19 Impact\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"name\":\"Blog\",\"description\":\"Roots Analysis\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\",\"name\":\"Roots Analysis\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"width\":205,\"height\":61,\"caption\":\"Roots Analysis\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RootsAnalysis\\\/\",\"https:\\\/\\\/x.com\\\/RootsAnalysis\",\"https:\\\/\\\/www.instagram.com\\\/rootsanalysis\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/roots-analysis\\\/\",\"https:\\\/\\\/www.pinterest.it\\\/analysis1340\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCwZF57vY1lnU0bNLej2zukg\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/e8e0ebc31296140424e1e7fcc11331bc\",\"name\":\"Gaurav Chaudhary\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1661cbb4c9924618db626ec780a3daf2ebd251e93753c083102682dba715ded6?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1661cbb4c9924618db626ec780a3daf2ebd251e93753c083102682dba715ded6?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1661cbb4c9924618db626ec780a3daf2ebd251e93753c083102682dba715ded6?s=96&d=mm&r=g\",\"caption\":\"Gaurav Chaudhary\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"COVID-19 Reshaped Cell and Gene Therapy Manufacturing","description":"According to Roots Analysis, the pandemic is likely to accelerate the development of cell and gene therapy manufacturing","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rootsanalysis.com\/blog\/covid-19-impact-on-cell-and-gene-therapy-manufacturing-market\/","og_locale":"en_US","og_type":"article","og_title":"COVID-19 Reshaped Cell and Gene Therapy Manufacturing","og_description":"According to Roots Analysis, the pandemic is likely to accelerate the development of cell and gene therapy manufacturing","og_url":"https:\/\/www.rootsanalysis.com\/blog\/covid-19-impact-on-cell-and-gene-therapy-manufacturing-market\/","og_site_name":"Blog","article_publisher":"https:\/\/www.facebook.com\/RootsAnalysis\/","article_published_time":"2020-03-29T15:44:32+00:00","article_modified_time":"2026-07-23T10:13:21+00:00","og_image":[{"width":1024,"height":507,"url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Impact-of-COVID-19-on-Cell-and-Gene-Therapy-Manufacturing-Roots.webp","type":"image\/webp"}],"author":"Gaurav Chaudhary","twitter_card":"summary_large_image","twitter_creator":"@RootsAnalysis","twitter_site":"@RootsAnalysis","twitter_misc":{"Written by":"Gaurav Chaudhary","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.rootsanalysis.com\/blog\/covid-19-impact-on-cell-and-gene-therapy-manufacturing-market\/#article","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/covid-19-impact-on-cell-and-gene-therapy-manufacturing-market\/"},"author":{"name":"Gaurav Chaudhary","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/e8e0ebc31296140424e1e7fcc11331bc"},"headline":"Cell and Gene Therapy Manufacturing: COVID-19 Impact","datePublished":"2020-03-29T15:44:32+00:00","dateModified":"2026-07-23T10:13:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/covid-19-impact-on-cell-and-gene-therapy-manufacturing-market\/"},"wordCount":677,"publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/covid-19-impact-on-cell-and-gene-therapy-manufacturing-market\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Impact-of-COVID-19-on-Cell-and-Gene-Therapy-Manufacturing-Roots.webp","keywords":["Cell Therapy","Gene Therapy"],"articleSection":["Cell Therapy","Gene Therapy","Vector Manufacturing"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.rootsanalysis.com\/blog\/covid-19-impact-on-cell-and-gene-therapy-manufacturing-market\/","url":"https:\/\/www.rootsanalysis.com\/blog\/covid-19-impact-on-cell-and-gene-therapy-manufacturing-market\/","name":"COVID-19 Reshaped Cell and Gene Therapy Manufacturing","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/covid-19-impact-on-cell-and-gene-therapy-manufacturing-market\/#primaryimage"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/covid-19-impact-on-cell-and-gene-therapy-manufacturing-market\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Impact-of-COVID-19-on-Cell-and-Gene-Therapy-Manufacturing-Roots.webp","datePublished":"2020-03-29T15:44:32+00:00","dateModified":"2026-07-23T10:13:21+00:00","description":"According to Roots Analysis, the pandemic is likely to accelerate the development of cell and gene therapy manufacturing","breadcrumb":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/covid-19-impact-on-cell-and-gene-therapy-manufacturing-market\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rootsanalysis.com\/blog\/covid-19-impact-on-cell-and-gene-therapy-manufacturing-market\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/covid-19-impact-on-cell-and-gene-therapy-manufacturing-market\/#primaryimage","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Impact-of-COVID-19-on-Cell-and-Gene-Therapy-Manufacturing-Roots.webp","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Impact-of-COVID-19-on-Cell-and-Gene-Therapy-Manufacturing-Roots.webp","width":1024,"height":507},{"@type":"BreadcrumbList","@id":"https:\/\/www.rootsanalysis.com\/blog\/covid-19-impact-on-cell-and-gene-therapy-manufacturing-market\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rootsanalysis.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Cell and Gene Therapy Manufacturing: COVID-19 Impact"}]},{"@type":"WebSite","@id":"https:\/\/www.rootsanalysis.com\/blog\/#website","url":"https:\/\/www.rootsanalysis.com\/blog\/","name":"Blog","description":"Roots Analysis","publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rootsanalysis.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization","name":"Roots Analysis","url":"https:\/\/www.rootsanalysis.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","width":205,"height":61,"caption":"Roots Analysis"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RootsAnalysis\/","https:\/\/x.com\/RootsAnalysis","https:\/\/www.instagram.com\/rootsanalysis\/","https:\/\/www.linkedin.com\/company\/roots-analysis\/","https:\/\/www.pinterest.it\/analysis1340\/","https:\/\/www.youtube.com\/channel\/UCwZF57vY1lnU0bNLej2zukg"]},{"@type":"Person","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/e8e0ebc31296140424e1e7fcc11331bc","name":"Gaurav Chaudhary","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/1661cbb4c9924618db626ec780a3daf2ebd251e93753c083102682dba715ded6?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1661cbb4c9924618db626ec780a3daf2ebd251e93753c083102682dba715ded6?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1661cbb4c9924618db626ec780a3daf2ebd251e93753c083102682dba715ded6?s=96&d=mm&r=g","caption":"Gaurav Chaudhary"}}]}},"_links":{"self":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/11360","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/users\/21"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/comments?post=11360"}],"version-history":[{"count":7,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/11360\/revisions"}],"predecessor-version":[{"id":22652,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/11360\/revisions\/22652"}],"wp:attachment":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/media?parent=11360"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/categories?post=11360"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/tags?post=11360"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}